学科主题临床医学
Liver Fibrosis and Hepatic Stellate Cells Improvement of Chronic Hepatitis C Patients by Interferon-beta-1a with or without Sustained Viral Response
Rao, Hui-ying1; Wei, Lai1; Li, Jing1; Zhang, Lan-fang1; Chen, Huan-yong2; Zhu, Li-min3; Liu, Feng1; Sun, Yan1; Wang, Hao1
关键词Chronic Hepatitis c Liver Fibrosis Interferon-beta Treatment
刊名HEPATO-GASTROENTEROLOGY
2009-03-01
56期:90页:328-334
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Gastroenterology & Hepatology ; Surgery
资助者National Science and Technology Key Study Plan of China ; National Science and Technology Key Study Plan of China
研究领域[WOS]Gastroenterology & Hepatology ; Surgery
关键词[WOS]SMOOTH-MUSCLE ACTIN ; VIRUS-INFECTION ; PLUS RIBAVIRIN ; PEGINTERFERON ALPHA-2A ; NATURAL-HISTORY ; IMAGE-ANALYSIS ; IN-VIVO ; THERAPY ; ACTIVATION ; DISEASE
英文摘要

Background/Aims: We aimed to assess liver fibrosis in biopsies from patients with chronic hepatitis C and relationship to different responses to interferon-beta-1a.

Methodology: 21 patients with chronic hepatitis C were divided into two groups randomly and treated with recombinant human interferon-beta-1a (IFN-beta-1a) or IFN-beta-1a plus ribavirin (RBV) for 24 weeks, then followed up for another 24 weeks. 42 liver biopsies of 21 patients before and after treatment respectively were evaluated on conventional histological assessment. Then we studied 21 patients liver biopsies by immunohistochemical analysis of alpha-smooth muscle actin (alpha-SMA) and collagen type III.

Results: A significant improvement in HAI fibrosis staging was detected after therapy in all sustained viral responders (SVR) and non-responders (NR) patients. The percentages of cases with HAI scores and fibrosis staging decreased obviously were 100.0% and 71.4% in SVR patients and 50.0% and 42.9% in NR patients. The patients with combination therapy or normal ALT on 48w would more often receive the HAI and fibrosis staging decrease. The significantly lower alpha-SMA-positive HSCs and mean expression level of collagen type III were detected in the post-treatment biopsies. The HAI, alpha-SMA, collagen type III values were significantly correlated with the values of the semiquantitative indexes of fibrosis.

Conclusions: IFN-beta-1a therapy is effective for patients with chronic hepatitis C on liver histology regardless of viral response. The alpha-SMA-positive HSCs and collagen type III expression are responsible for liver fibrosis.

语种英语
所属项目编号2001BA705B06 ; 2004BA718B10 ; 2008ZX10002-013
资助者National Science and Technology Key Study Plan of China ; National Science and Technology Key Study Plan of China
WOS记录号WOS:000266094700010
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/57413
专题北京大学第二临床医学院_北京大学肝病研究所
作者单位1.Peking Univ, Inst Hepatol, Peoples Hosp, Beijing 100044, Peoples R China
2.Harbin Med Coll, Affiliated Hosp 1, Harbin, Peoples R China
3.Tianjin Infect Dis Hosp, Tianjin, Peoples R China
推荐引用方式
GB/T 7714
Rao, Hui-ying,Wei, Lai,Li, Jing,et al. Liver Fibrosis and Hepatic Stellate Cells Improvement of Chronic Hepatitis C Patients by Interferon-beta-1a with or without Sustained Viral Response[J]. HEPATO-GASTROENTEROLOGY,2009,56(90):328-334.
APA Rao, Hui-ying.,Wei, Lai.,Li, Jing.,Zhang, Lan-fang.,Chen, Huan-yong.,...&Wang, Hao.(2009).Liver Fibrosis and Hepatic Stellate Cells Improvement of Chronic Hepatitis C Patients by Interferon-beta-1a with or without Sustained Viral Response.HEPATO-GASTROENTEROLOGY,56(90),328-334.
MLA Rao, Hui-ying,et al."Liver Fibrosis and Hepatic Stellate Cells Improvement of Chronic Hepatitis C Patients by Interferon-beta-1a with or without Sustained Viral Response".HEPATO-GASTROENTEROLOGY 56.90(2009):328-334.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Rao, Hui-ying]的文章
[Wei, Lai]的文章
[Li, Jing]的文章
百度学术
百度学术中相似的文章
[Rao, Hui-ying]的文章
[Wei, Lai]的文章
[Li, Jing]的文章
必应学术
必应学术中相似的文章
[Rao, Hui-ying]的文章
[Wei, Lai]的文章
[Li, Jing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。